Blog Topic: Bioanalytical
Podcast: The Logic Behind Biologic Antibody Drug Names
In this podcast, we explain what International Non-proprietary Names are, and the logic behind their use.
- Dec 05, 2019
- 1 min read
- Kimberley Bryon-Dodd, PhD
WHO Decides What’s INN a Biologics Name?
This blog takes a look at the logic behind the names of monoclonal antibody drugs and implications of the more recent changes in the naming structure.
- Jun 13, 2019
- 5 min read
- Kimberley Bryon-Dodd, PhD
Getting the Dose Right
This blog discusses therapeutic drug monitoring and why it is used for conditions such as IBD to ensure that treatment remains safe and effective.
- May 15, 2018
- 4 min read
- Kimberley Bryon-Dodd, PhD
High affinity antibodies for improved analysis of antibody drugs
This blog post provides insight on how to improve your assay sensitivity by selecting antibodies based on binding strength as well as affinity.
- Dec 17, 2015
- 2 min read
- Bio-Rad
Immuno-MRM analyses: high-affinity recombinant antibody fragments
This blog post describes the applicability of recombinant antibody fragments from a naive antibody library for immuno-MRM based quantification.
- Oct 28, 2015
- 2 min read
- Bio-Rad